139 related articles for article (PubMed ID: 37818504)
1. Oxybutynin for Primary Palmer Hyperhidrosis Attenuates Migraine Attacks and Burdens.
Katsuki M
Cureus; 2023 Sep; 15(9):e44826. PubMed ID: 37818504
[TBL] [Abstract][Full Text] [Related]
2. The Efficacy of Japanese Herbal Kampo Medicine as an Acute and Prophylactic Medication to Treat Chronic Daily Headache and Medication Overuse Headache:-Single Arm Retrospective Study.
Katsuki M; Kashiwagi K; Kawamura S; Koh A
Cureus; 2022 May; 14(5):e25419. PubMed ID: 35769688
[TBL] [Abstract][Full Text] [Related]
3. Medication Overuse Headache Successfully Treated by Three Types of Japanese Herbal Kampo Medicine.
Katsuki M; Kawamura S; Kashiwagi K; Koh A
Cureus; 2021 Jul; 13(7):e16800. PubMed ID: 34513406
[TBL] [Abstract][Full Text] [Related]
4. A novel lotion formulation of 20% oxybutynin hydrochloride for the treatment of primary palmar hyperhidrosis: A randomized, placebo-controlled, double-blind, phase III study.
Fujimoto T; Terahara T; Okawa K; Inakura H; Hirayama Y; Yokozeki H
J Am Acad Dermatol; 2023 Jul; 89(1):62-69. PubMed ID: 36990320
[TBL] [Abstract][Full Text] [Related]
5. A randomized placebo-controlled trial of oxybutynin for the initial treatment of palmar and axillary hyperhidrosis.
Wolosker N; de Campos JR; Kauffman P; Puech-Leão P
J Vasc Surg; 2012 Jun; 55(6):1696-700. PubMed ID: 22341836
[TBL] [Abstract][Full Text] [Related]
6. Efficacy, Safety and Quality of Life of Oxybutynin versus Aluminum Chloride Hexahydrate in Treating Primary Palmar Hyperhidrosis.
Attallah HS; El-Gilany AH; Youssef YEB; Abdelshaheed ME; Sharaf EFA
Indian J Dermatol; 2022; 67(3):222-227. PubMed ID: 36386101
[TBL] [Abstract][Full Text] [Related]
7. Oxybutynin gel versus nanoemulgel for treating primary palmar hyperhidrosis: A pilot double-blind randomized controlled trial.
Saki N; Shakouri N; Rastaghi F; Hosseini SA; Alipour S; Ahramiyanpour N
J Cosmet Dermatol; 2023 Aug; 22(8):2268-2272. PubMed ID: 36999480
[TBL] [Abstract][Full Text] [Related]
8. [Use of oral oxybutynin at 7.5 mg per day in primary hyperhidrosis].
Try C; Messikh R; Elkhyat A; Aubin F; Humbert RP
Rev Med Liege; 2012 Oct; 67(10):520-6. PubMed ID: 23167161
[TBL] [Abstract][Full Text] [Related]
9. Topical Oxybutynin 3% Gel Versus Aluminum Chloride 15% Lotion in Treatment of Primary Focal Hyperhidrosis.
El-Agamy El-Samadony A; Hegab DS; El Maghraby GM; El-Maadawy IH
Dermatol Pract Concept; 2023 Jul; 13(3):. PubMed ID: 37557105
[TBL] [Abstract][Full Text] [Related]
10. Oxybutynin: dry days for patients with hyperhidrosis.
Mijnhout GS; Kloosterman H; Simsek S; Strack van Schijndel RJ; Netelenbos JC
Neth J Med; 2006 Oct; 64(9):326-8. PubMed ID: 17057269
[TBL] [Abstract][Full Text] [Related]
11. Compensatory hyperhidrosis: results of pharmacologic treatment with oxybutynin.
Teivelis MP; Wolosker N; Krutman M; Milanez de Campos JR; Kauffman P; Puech-Leão P
Ann Thorac Surg; 2014 Nov; 98(5):1797-802. PubMed ID: 25173719
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and quality of life outcomes of oxybutynin for treating palmar hyperhidrosis in children younger than 14 years old.
Wolosker N; Schvartsman C; Krutman M; Campbell TP; Kauffman P; de Campos JR; Puech-Leão P
Pediatr Dermatol; 2014; 31(1):48-53. PubMed ID: 23627681
[TBL] [Abstract][Full Text] [Related]
13. Quality of life before hyperhidrosis treatment as a predictive factor for oxybutynin treatment outcomes in palmar and axillary hyperhidrosis.
Wolosker N; Krutman M; Teivelis MP; Campbell TP; Kauffman P; de Campos JR; Puech-Leão P
Ann Vasc Surg; 2014 May; 28(4):970-6. PubMed ID: 24333527
[TBL] [Abstract][Full Text] [Related]
14. Treatment of uncommon sites of focal primary hyperhidrosis: experience with pharmacological therapy using oxybutynin.
Teivelis MP; Wolosker N; Krutman M; Kauffman P; Campos JR; Puech-Leão P
Clinics (Sao Paulo); 2014 Sep; 69(9):608-14. PubMed ID: 25318092
[TBL] [Abstract][Full Text] [Related]
15. Combined treatment of palmar hyperhidrosis with botulinum toxin type A and oxybutynin chloride: Results of a clinical, multicenter, prospective study.
Campanati A; Gregoriou S; Consales V; Rizzetto G; Bobyr I; Diotallevi F; Martina E; Kontochristopoulos G; Platsidaki E; Offidani A
Dermatol Ther; 2020 Nov; 33(6):e14039. PubMed ID: 32691938
[TBL] [Abstract][Full Text] [Related]
16. Long-term evaluation of the safety and efficacy of a novel 20% oxybutynin hydrochloride lotion for primary palmar hyperhidrosis: An open-label extension study.
Fujimoto T; Terahara T; Okawa K; Inakura H; Hirayama Y; Yokozeki H
J Dermatol; 2023 Nov; 50(11):1459-1472. PubMed ID: 37605375
[TBL] [Abstract][Full Text] [Related]
17. An alternative to treat palmar hyperhidrosis: use of oxybutynin.
Wolosker N; de Campos JR; Kauffman P; Neves S; Yazbek G; Jatene FB; Puech-Leão P
Clin Auton Res; 2011 Dec; 21(6):389-93. PubMed ID: 21688168
[TBL] [Abstract][Full Text] [Related]
18. Videothoracoscopic Sympathectomy Results after Oxybutynin Chloride Treatment Failure.
Lembrança L; Wolosker N; de Campos JRM; Kauffman P; Teivelis MP; Puech-Leão P
Ann Vasc Surg; 2017 Aug; 43():283-287. PubMed ID: 28478174
[TBL] [Abstract][Full Text] [Related]
19. Long-term results of oxybutynin treatment for palmar hyperhidrosis.
Wolosker N; Teivelis MP; Krutman M; de Paula RP; de Campos JR; Kauffman P; Puech-Leão P
Clin Auton Res; 2014 Dec; 24(6):297-303. PubMed ID: 25427685
[TBL] [Abstract][Full Text] [Related]
20. Long-Term Efficacy of Oxybutynin for Palmar and Plantar Hyperhidrosis in Children Younger than 14 Years.
Wolosker N; Teivelis MP; Krutman M; de Paula RP; Schvartsman C; Kauffman P; de Campos JR; Puech-Leão P
Pediatr Dermatol; 2015; 32(5):663-7. PubMed ID: 25490865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
